Heart Failure 2015 - 2nd World Congress on Acute Heart Failure 2015

23 - 26 May 2015, Seville - Spain

Session Details

Poster session 1 Saturday 08:30 -17:30: Co-morbidities
Sat 23 May 08:30 - 17:30 Miscellaneous Poster Session Poster Area
Learning Objectives: Presenters are requested to be by their poster for the coffee breaks and lunch time. Posters on display from 08:30 – 17:30 Morning Coffee Break 10:00 – 10:30 Lunch time 12:15 – 14:00 Afternoon Coffee Break 15:45 – 16:00

Access slides, videos, reports online via ESC Congress 365 Other resources

List of Presentations

Related documents
08:30P310Management and diagnosis of patients with syncope admitted to a general hospitalJoana Catarina DUARTE RODRIGUES (Oporto, Portugal)
08:30P311Validating diagnostic accuracy of a portable sleep testing diagnostic device in an outpatient population of heart failure patients with sleep disordered breathingManuel ARAUJO (Lisbon, Portugal)
08:30P312Respiratory disorders during sleep in patients with chronic heart failureViktoriya NEPRAN (Saint-Petersburg, Russian Federation)
08:30P313The role of bariatric surgery for improvement of hypertension in obese patients Renata PETRONI (L'aquila, Italy)
08:30P314Clinical efficacy and safety of formoterol and tiotropium administration in patient with chronic heart failure due to coronary artery disease combined with chronic obstructive pulmonary diseaseAnna EVDOKIMOVA (Moscow, Russian Federation)
08:30P315Renal status in patients with worsening heart failure hospitalized for acute decompensated heart failure 
08:30P316Noncardiac pathology in patients with negative ventricular remodeling over 1 year after coronary revascularization.Aliona GRIVENCO (Chisinau, Moldova, Republic of)
08:30P317Clinical impact of cognitive impairment on patient's post-discharge environment in patients with hospitalized heart failureMasaki ISHIYAMA (Ise, Japan)
08:30P318Eritrocitary indexes as predictors of the cause of anemia or nutritional deficit in heart failure patientsPatricia MONIZ (Lisboa, Portugal)
08:30P319Portable sleep monitor - an automatic screening method for sleep-disordered breathing in heart failure patientsPatricia PEREIRA (Lisbon, Portugal)
08:30P320Depression as an independent risk factor for all-cause mortality in heart failure patients.Ioanna SOKORELI (Eindhoven, Netherlands)
08:30P321Diabetes as a risk factor of stroke and death in heart failure patients in sinus rhythm - a nationwide cohort studyLine MELGAARD (Aalborg, Denmark)
08:30P322Relationship between diastolic stiffness assessed by diastolic wall strain and cardiac toxicity from trastuzumabMasato ARAO (Tokyo, Japan)
08:30P323Predictive value of cardiac troponins in the development of chronic anthracycline-induced cardiomyopathyMichaela ADAMCOVA (Hradec Kralove, Czech Republic)
08:30P324Serial cardiac biomarker and echocardiographic evaluation for the early detection of antrcycline + trastuzumab cardiotoxicitySavina NODARI (Brescia, Italy)
08:30P325Biventricular myocardial deformation in hematological malignancies explored by velocity vector imagingFarouk MOOKADAM (Scottsdale, United States of America)
08:30P326Cardiac toxicity associated to trastuzumab treatment in usual clinical practiceGonzalo GALLEGO SANCHEZ (Albacete, Spain)
08:30P327Heart failure as a consequence or in association with cancerKevin MOHEE (Grimsby, United Kingdom)
08:30P328Early changes in left ventricular diastolic function after chemotherapy predict subsequent NT-proBNP elevation in breast cancer patientsAndreia MAGALHAES (Odivelas, Portugal)
08:30P329There are no differences in clinical picture of heart failure in patients with and without cancer. Grzegorz PIOTROWSKI (Lodz, Poland)
08:30P330Intrapericardial treatment with bleomycin in neoplastic pericardial effusion: our experience in the last 4 yearsMartin GARCIA GONZALEZ (Santa Cruz De Tenerife, Spain)
08:30P331Ultrafiltration therapy in patients with severe heart failure and resistance to diuretic treatments.Gabriele DI GESARO (Palermo, Italy)
08:30P332Phenotypes of cardiorenal interrelations in patients with acute cardiac diseasesSvetlana VILLEVALDE (Moscow, Russian Federation)
08:30P333Prevalence and outcomes in community-acquired versus hospital-acquired acute kidney injury in patients with decompensated heart failureSvetlana VILLEVALDE (Moscow, Russian Federation)
08:30P334Clinical characteristics of chronic kidney disease in patients hospitalized for acute decompensated heart failureAlice BALACEANU (Bucharest, Romania)
08:30P335Differences in treatment intensity and outcomes of acute heart failure and the cardio-renal syndrome: a cohort studyLuiz PASSOS (Salvador, Brazil)
08:30P336Arterial wall remodeling depending on filtration renal function in patients with chronic heart failure and preserved ejection fraction.Natalia KOZIOLOVA (Perm, Russian Federation)
08:30P337Heart and kidney damage in infective endocarditisElizaveta KOTOVA (Moscow, Russian Federation)
08:30P338Increased renal arterial resistances are independently associated to microalbuminura in chronic heart failure outpatients.Massimo IACOVIELLO (Bari, Italy)